Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 23, 2019
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates NeuroinflammationCatherine Huck, David Leppert, Vanessa Wegert, et al.
Journal of Neuroimmunology|October 7, 2009
AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritisZhi-Yuan Zhang, Zhiren Zhang, Caroline Zug, et al.
Acta Neuropathologica|December 10, 2002
Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathiesSusanne Renaud, Beat Erne, Peter Fuhr, et al.
Multiple Sclerosis and Related Disorders|September 21, 2016
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and designFrancois Curtin, Herve Porchet, Robert Glanzman, et al.
Journal of Neuroimmunology|February 2, 2010
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain proteinJens Kuhle, Axel Regeniter, David Leppert, et al.
CNS Drugs|December 17, 2011
Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosisHenrik Gensicke, David Leppert, Özgür Yaldizli, et al.
Scientific Reports|September 23, 2022
Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parametersMarco Hermesdorf, David Leppert, Aleksandra Maceski, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 2, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosisMaija Saraste, Markus Matilainen, Anna Vuorimaa, et al.
Geroscience|June 7, 2023
Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysisMarco Hermesdorf, Niklas Wulms, Aleksandra Maceski, et al.
Pageof 17